Home/Filings/4/0001453687-21-000134
4//SEC Filing

Kishimoto Takashi Kei 4

Accession 0001453687-21-000134

CIK 0001453687other

Filed

Oct 4, 8:00 PM ET

Accepted

Oct 5, 4:26 PM ET

Size

5.6 KB

Accession

0001453687-21-000134

Insider Transaction Report

Form 4
Period: 2021-10-01
Kishimoto Takashi Kei
Chief Scientific Officer
Transactions
  • Award

    Common Stock

    2021-10-01+13,750194,281 total
Footnotes (2)
  • [F1]On January 4, 2021, the reporting person was granted performance based restricted stock units for an aggregate of 27,500 shares of the Issuer's common stock (the "Performance RSUs"), which may be earned based on the achievement of two separate performance conditions related to the Issuer's operating and research and development activities. Any Performance RSUs will generally vest in two equal installments upon the dates of achievement of each of the two performance conditions, subject to continued employment, so long as each performance condition is met before December 31, 2021. The compensation committee of the board of directors of the Issuer has determined that the first of the performance conditions has been met, and accordingly 13,750 Performance RSUs vested on October 1, 2021.
  • [F2]Includes 2,753 shares of common stock purchased under the Issuer's Employee Stock Purchase Program during the contribution period between March 1, 2021 and August 31, 2021.

Issuer

SELECTA BIOSCIENCES INC

CIK 0001453687

Entity typeother

Related Parties

1
  • filerCIK 0001676930

Filing Metadata

Form type
4
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 4:26 PM ET
Size
5.6 KB